Sleep Eze D Extra Strength Caplet 50mg 50 mg Tablet is a Health Canada–registered human drug (DIN 01933450) held by Whitehall-Robins Inc., containing Diphenhydramine Hydrochloride. Health Canada lists its status as Cancelled Post Market (status date 07 Aug 1997). Nexara Health has matched 966 registrations of Diphenhydramine Hydrochloride across 19 other regulated markets, 7 of them in the same strength and dosage form.

Health Canada registration

Diphenhydramine Hydrochloride registered in other markets

966 registrations of the same molecule in 19 national registries outside Canada (first 79 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Diphenhydramine Hydrochloride worldwide →

Regulator price references for Diphenhydramine Hydrochloride

Published list or reimbursement prices for Diphenhydramine Hydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Sleep Eze D Extra Strength Caplet 50mg (DIN 01933450) marketed in Canada?

No. Health Canada lists DIN 01933450 as Cancelled Post Market as of 07 Aug 1997.

Who holds the Canadian licence for this product?

Whitehall-Robins Inc. is the company of record in the Health Canada Drug Product Database.

Is Diphenhydramine Hydrochloride registered outside Canada?

Yes — Nexara Health has matched 966 registrations in 19 other markets, including 7 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 01933450, status date 1997-08-07; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, Medicines Authority, NHRA, NHS dm+d VMP, NPRA, SFDA, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, DoH SEP database, EDE, eEKO (Erstattungskodex), NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 01933450, status date 1997-08-07; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, Medicines Authority, NHRA, NHS dm+d VMP, NPRA, SFDA, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, DoH SEP database, EDE, eEKO (Erstattungskodex), NHRA, SFDA.

Health Canada Drug Product Database (DPD), DIN 01933450, status date 1997-08-07; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, Medicines Authority, NHRA, NHS dm+d VMP, NPRA, SFDA, TFDA, TITCK, URPL RPL; price sources: CNOPS liste des medicaments, DoH SEP database, EDE, eEKO (Erstattungskodex), NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.